C. Browne

Impact of apixaban vs low molecular weight heparin/vitamin k antagonist on hospital resource use in patients with venous thromboembolism

A. Cohen, T. Lanitis, J. Mardekian, 2017, Journal of medical economics.

Cost-effectiveness of Apixaban Versus Other Oral Anticoagulants for the Initial Treatment of Venous Thromboembolism and Prevention of Recurrence.

A. Cohen, T. Lanitis, R. Leipold, 2016, Clinical therapeutics.

Patient preferences in Italy: health state utilities associated with attributes of weekly injection devices for treatment of type 2 diabetes

L. Matza, M. Orsini Federici, K. Boye, 2017, Patient Preference and Adherence.

Cost-effectiveness of silicone and alginate impressions for complete dentures

C. Hulme, S. Pavitt, J. O’Dwyer, 2014, BDJ.

Use of Bayesian Markov Chain Monte Carlo Methods to Estimate EQ-5D Utility Scores from EORTC QLQ Data in Myeloma for Use in Cost-Effectiveness Analysis

Julia Brown, Samer A Kharroubi, Christopher McCabe, 2015, Medical decision making : an international journal of the Society for Medical Decision Making.

Epidemiological and economic burden of Clostridium difficile in the United States: estimates from a modeling approach

E. Dubberke, V. Prabhu, T. Mast, 2016, BMC Infectious Diseases.

Cost-effectiveness of apixaban versus low molecular weight heparin/vitamin k antagonist for the treatment of venous thromboembolism and the prevention of recurrences

A. Cohen, T. Lanitis, R. Leipold, 2017, BMC Health Services Research.

Estimating quality-adjusted life years from patient-reported visual functioning

C Browne, J. Brazier, M. Jofre-Bonet, 2012, Eye.

Cost-effectiveness of silicone and alginate impressions for complete dentures

H. Craddock, C. Browne, M. Godfrey, 2014, Journal of dentistry.